Sean Puri: Enduring Ventures is worth over $100M
“Enduring Ventures has turned out to be pretty big. It's a hundred million dollar plus company now.”
Kozinsky: Enduring Ventures is designed around a 20-to-40-year horizon
“The next thing we do, let's reverse engineer. What is the last business we would ever want to work on? Right? Like, What is something that we would want to work on for the next 2030 or 40 years, which is really different from our startup experience”
Kozinsky: Enduring Ventures will wait 3-6 months before aggressively deploying capital
“Xavier and I, you know, relative to maybe a year ago, we're still investing. We're still looking at opportunities, but we're happy to be patient for another three to six months to see where kind of the world lands, where everything resets and then pick up the …”
Helgeson: First ~$8M raised by Enduring Ventures qualifies as QSBS
“So all of our original investors along with me and Cieva have that treatment in the company. And you do as well as an investor. I think about the first eight million that we raised qualified as QSPS.”
Kozinsky: Clinical Trial Startup Charged Pharma $10k–$20k Per Patient
“So it was a marketplace model, and our customers were like Pfizer and Novartis and Inovoderm, and they would pay us 10 to 20,000 dollars per patient to recruit a patient. We would split that with the doctor.”
Kozinsky: Enduring Ventures owns 12 businesses, mostly from retiring owners
“We are now owners of 12 businesses two of them or three of them actually are tech companies. We also have a venture studio, so we've started a couple of businesses, but 90% of what we do is we buy businesses that are generating cash flow from retiring owners.”
Kozinsky: Founders should start exit planning 3 to 5 years early
“I actually recommend, at the very least, thinking about your sale process three years before you plan to do it, and ideally even four or five years if you're not in a rush, right, because you can really optimize your business for the sale”